Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4 Kuchena >98.0% (HPLC) Lenvatinib Mesylate Intermediate Factory

Tsanangudzo Pfupi:

Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate

CAS: 205448-66-4

Kuchena:> 98.0% (HPLC)

Chitarisiko: Kubva-Kuchena kusvika kuYellow Solid Powder

Pakati peLenvatinib Mesylate CAS 857890-39-2

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate
Mashoko anoreva zvakafanana Lenvatinib Kusachena 47;4-Chloro-7-Methoxyquinoline-6-Carboxylic Acid Methyl Ester;4-Chloro-7-Methoxy-6-Quinolinecarboxylic Acid Methyl Ester;Lenvaint-D
Nhamba yeCAS 205448-66-4
Nhamba yeCAT RF-PI1970
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C12H10ClNO3
Molecular Weight 251.67
Boiling Point 377.4±37.0℃
Density 1.320±0.06 g/cm3
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Off-White kusvika Yellow Solid Powder
1 H NMR Spectrum Zvinoenderana Nechimiro
Kuchena / Analysis Method >98.0% (HPLC)
Kurasika paKuomesa <1.00%
Zvose Zvisina Kuchena <2.00%
Test Standard Enterprise Standard
Usage Pakati/Kusachena kweLenvatinib Mesylate (CAS: 857890-39-2)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

1

FAQ:

Application:

Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate (CAS: 205448-66-4) iri pakati peLenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib imishonga yekenza yekenza yakagadzirwa neEisai Corporation yeJapan (Code: E7080), iri ye inhibitor ye oral multi-receptor tyrosine kinase (RTK) uye inogona kudzivisa kinase chiitiko chevascular endothelial growth factor Receptors R1 (FLT1), VEG-FR2 (KDR), R3 (FLT4).Lenvatinib inogonawo kudzivisa kubatanidzwa kwemamwe maRTK mu pathological angiogenesis, tumor kukura, uye kukura kwekenza kunze kwemaitiro avo emagetsi emagetsi anosanganisira fibroblast growth factor (FGF) receptors FGFR1, 2, 3, uye 4;platelet-derived growth factor receptor (PDGFR [alpha]), KIT, uye RET.[Zviratidzo]: Lenvatinib inokodzera kurapwa kwevarwere vekenza yethyroid yemunharaunda kudzoka kana metastasis rudzi, progressivity rudzi uye radioactive iodine-refractory differentiated type.

Nyora meseji yako pano uye titumire kwatiri